Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Oct 20;26(4):545-552.
doi: 10.18865/ed.26.4.545.

Review: Hemodynamic Characteristics and Outcomes of Sickle Cell Disease Associated Pulmonary Hypertension

Alem Mehari  1 , Alvin V Thomas  1 , Alicia N Thomas  1 , Mark S Johnson  2
Affiliations
Review

Review: Hemodynamic Characteristics and Outcomes of Sickle Cell Disease Associated Pulmonary Hypertension

Alem Mehari et al. Ethn Dis. .

Abstract

Pulmonary hypertension (PH) is a leading cause of morbidity and early mortality in adults with sickle cell disease (SCD). However, the prevalence, hemodynamic profile and prognosis of SCD-PH remain controversial and need frequent updates. Pulmonary hypertension determined by right heart catheterization (RHC) occurs in 6% to 10% of adults with SCD. Hemodynamically, SCD-PH may be pre-capillary or post-capillary in nature. The exact etiology is unknown and often multifactorial; hence a thorough diagnostic evaluation following established PH guidelines is essential to determine disease prevalence, etiology and outcomes. Data on the efficacy and safety of pulmonary arterial hypertension (PAH) therapy are limited in SCD; clinical trials in these patients are urgently needed. This review provides an overview of RHC-determined hemodynamic characteristics, current management modality and outcomes; we also highlight recent advances and unmet research needs in SCD-PH.

Keywords: Hemodynamics; Pulmonary Hypertension; Sickle Cell Disease.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

References

    1. Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376(9757):2018-2031. 10.1016/S0140-6736(10)61029-X - DOI - PubMed
    1. Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010;38(4)(suppl):S512-S521. 10.1016/j.amepre.2009.12.022 - DOI - PubMed
    1. Stuart MJ, Nagel RL. Sickle-cell disease. Lancet. 2004;364(9442):1343-1360. 10.1016/S0140-6736(04)17192-4 - DOI - PubMed
    1. Farrell K, Dent L, Nguyen ML, Buchowski M, Bhatt A, Aguinaga MP. The relationship of oxygen transport and cardiac index for the prevention of sickle cell crises. J Natl Med Assoc. 2010;102(11):1000-1007. 10.1016/S0027-9684(15)30726-4 - DOI - PMC - PubMed
    1. Ballas SK, Mohandas N. Sickle red cell microrheology and sickle blood rheology. Microcirculation. 2004;11(2):209-225. 10.1080/10739680490279410 - DOI - PubMed

Publication types

LinkOut - more resources